Arrowhead Research Corp Director Sells $50,305 in Stock (ARWR)
Arrowhead Research Corp (NASDAQ:ARWR) Director Edward W. Frykman unloaded 3,148 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $15.98, for a total transaction of $50,305.04. Following the completion of the transaction, the director now directly owns 23,852 shares of the company’s stock, valued at approximately $381,155. The transaction was disclosed in a filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Arrowhead Research Corp from $15.00 to $30.00 in a research note to investors on Friday.
Shares of Arrowhead Research Corp (NASDAQ:ARWR) traded up 4.29% during mid-day trading on Monday, hitting $17.99. The stock had a trading volume of 1,366,220 shares. Arrowhead Research Corp has a 1-year low of $1.65 and a 1-year high of $18.00. The stock has a 50-day moving average of $12.57 and a 200-day moving average of $7.7. The company’s market cap is $714.0 million.
Arrowhead Research Corp (NASDAQ:ARWR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.33) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.18) by $0.15. On average, analysts predict that Arrowhead Research Corp will post $-0.80 earnings per share for the current fiscal year.
Arrowhead Research Corporation (NASDAQ:ARWR) is a nanomedicine company engaged in development therapeutic products at the interface of biology and nano-engineering to cure disease and improve human health.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.